{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T08:58:31Z","timestamp":1776502711155,"version":"3.51.2"},"reference-count":57,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.3892\/or.2015.4408","type":"journal-article","created":{"date-parts":[[2015,11,10]],"date-time":"2015-11-10T11:12:58Z","timestamp":1447153978000},"page":"1041-1048","source":"Crossref","is-referenced-by-count":17,"title":["MARCKSL1 exhibits anti-angiogenic effects through suppression of VEGFR-2-dependent Akt\/PDK-1\/mTOR phosphorylation"],"prefix":"10.3892","volume":"35","author":[{"given":"BOH-RAM","family":"KIM","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SEUNG-HOON","family":"LEE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MI-SUN","family":"PARK","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SEUNG-HEE","family":"SEO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YOUNG-MIN","family":"PARK","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YOUNG-JOO","family":"KWON","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SEUNG-BAE","family":"RHO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2015,11,10]]},"reference":[{"key":"key20180107211201_b1-or-35-02-1041","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.cellsig.2005.07.010","article-title":"Protein kinase C and the regulation of the actin cytoskeleton","volume":"18","author":"Larsson","year":"2006","journal-title":"Cell Signal"},{"key":"key20180107211201_b2-or-35-02-1041","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1074\/jbc.M110.196022","article-title":"The MARCKS protein plays a critical role in phosphatidylinositol 4,5-bisphosphate metabolism and directed cell movement in vascular endothelial cells","volume":"286","author":"Kalwa","year":"2011","journal-title":"J Biol Chem"},{"key":"key20180107211201_b3-or-35-02-1041","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/0092-8674(92)90546-O","article-title":"The MARCKS brothers: A family of protein kinase C substrates","volume":"71","author":"Aderem","year":"1992","journal-title":"Cell"},{"key":"key20180107211201_b4-or-35-02-1041","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/(SICI)1096-9861(19980803)397:3<337::AID-CNE3>3.0.CO;2-3","article-title":"Distribution of the protein kinase C substrates MARCKS and MRP in the postnatal developing rat brain","volume":"397","author":"McNamara","year":"1998","journal-title":"J Comp Neurol"},{"key":"key20180107211201_b5-or-35-02-1041","doi-asserted-by":"crossref","first-page":"33619","DOI":"10.1074\/jbc.273.50.33619","article-title":"MacMARCKS is not essential for phagocytosis in macrophages","volume":"273","author":"Underhill","year":"1998","journal-title":"J Biol Chem"},{"key":"key20180107211201_b6-or-35-02-1041","doi-asserted-by":"crossref","first-page":"23948","DOI":"10.1074\/jbc.M001845200","article-title":"Protein kinase C-regulated dynamitin-macrophage-enriched myristoylated alanine-rice C kinase substrate interaction is involved in macrophage cell spreading","volume":"275","author":"Yue","year":"2000","journal-title":"J Biol Chem"},{"key":"key20180107211201_b7-or-35-02-1041","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj3620001","article-title":"Cross-talk unfolded: MARCKS proteins","volume":"362","author":"Arbuzova","year":"2002","journal-title":"Biochem J"},{"key":"key20180107211201_b8-or-35-02-1041","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1128\/MCB.00713-12","article-title":"c-Jun N-terminal kinase phosphorylation of MARCKSL1 determines actin stability and migration in neurons and in cancer cells","volume":"32","author":"Bj\u00f6rkblom","year":"2012","journal-title":"Mol Cell Biol"},{"key":"key20180107211201_b9-or-35-02-1041","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.bbrc.2009.03.077","article-title":"MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells","volume":"383","author":"Li","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180107211201_b10-or-35-02-1041","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.cellsig.2014.05.010","article-title":"Lysyl oxidase-like 2 (LOXL2) controls tumor-associated cell proliferation through the interaction with MARCKSL1","volume":"26","author":"Kim","year":"2014","journal-title":"Cell Signal"},{"key":"key20180107211201_b11-or-35-02-1041","doi-asserted-by":"crossref","first-page":"10931","DOI":"10.1016\/S0021-9258(19)49853-0","article-title":"Angiogenesis","volume":"267","author":"Folkman","year":"1992","journal-title":"J Biol Chem"},{"key":"key20180107211201_b12-or-35-02-1041","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/386671a0","article-title":"Mechanisms of angiogenesis","volume":"386","author":"Risau","year":"1997","journal-title":"Nature"},{"key":"key20180107211201_b13-or-35-02-1041","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/nrc909","article-title":"VEGF and the quest for tumour angiogenesis factors","volume":"2","author":"Ferrara","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"key20180107211201_b14-or-35-02-1041","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0008-6363(02)00221-3","article-title":"The wnt-frizzled cascade in cardiovascular disease","volume":"55","author":"van Gijn","year":"2002","journal-title":"Cardiovasc Res"},{"key":"key20180107211201_b15-or-35-02-1041","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1242\/dev.016865","article-title":"Wnt signaling: An essential regulator of cardiovascular differentiation, morphogenesis and progenitor self-renewal","volume":"135","author":"Cohen","year":"2008","journal-title":"Development"},{"key":"key20180107211201_b16-or-35-02-1041","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10456-008-9095-3","article-title":"Wnt\/Frizzled signaling in angiogenesis","volume":"11","author":"Zerlin","year":"2008","journal-title":"Angiogenesis"},{"key":"key20180107211201_b17-or-35-02-1041","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.devcel.2009.01.004","article-title":"The control of vascular integrity by endothelial cell junctions: Molecular basis and pathological implications","volume":"16","author":"Dejana","year":"2009","journal-title":"Dev Cell"},{"key":"key20180107211201_b18-or-35-02-1041","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.gde.2009.09.004","article-title":"Vascular morphogenesis: A Wnt for every vessel?","volume":"19","author":"Franco","year":"2009","journal-title":"Curr Opin Genet Dev"},{"key":"key20180107211201_b19-or-35-02-1041","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1161\/CIRCRESAHA.110.223750","article-title":"The role of wnt signaling in physiological and pathological angiogenesis","volume":"107","author":"Dejana","year":"2010","journal-title":"Circ Res"},{"key":"key20180107211201_b20-or-35-02-1041","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1083\/jcb.129.4.895","article-title":"Endothelial receptor tyrosine kinases involved in angiogenesis","volume":"129","author":"Mustonen","year":"1995","journal-title":"J Cell Biol"},{"key":"key20180107211201_b21-or-35-02-1041","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/978-1-4615-4221-6_5","article-title":"Endothelial receptor tyrosine kinases involved in blood vessel development and tumor angiogenesis","volume":"476","author":"Breier","year":"2000","journal-title":"Adv Exp Med Biol"},{"key":"key20180107211201_b22-or-35-02-1041","doi-asserted-by":"crossref","first-page":"C1358","DOI":"10.1152\/ajpcell.2001.280.6.C1358","article-title":"Role of vascular endothelial growth factor in regulation of physiological angiogenesis","volume":"280","author":"Ferrara","year":"2001","journal-title":"Am J Physiol Cell Physiol"},{"key":"key20180107211201_b23-or-35-02-1041","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1749-6632.2003.tb03223.x","article-title":"Comparative structure-function analysis of VEGFR-1 and VEGFR-2: What have we learned from chimeric systems?","volume":"995","author":"Meyer","year":"2003","journal-title":"Ann NY Acad Sci"},{"key":"key20180107211201_b24-or-35-02-1041","doi-asserted-by":"crossref","first-page":"5523","DOI":"10.1038\/sj.onc.1207712","article-title":"Substitution of C-terminus of VEGFR-2 with VEGFR-1 promotes VEGFR-1 activation and endothelial cell proliferation","volume":"23","author":"Meyer","year":"2004","journal-title":"Oncogene"},{"key":"key20180107211201_b25-or-35-02-1041","doi-asserted-by":"crossref","first-page":"12018","DOI":"10.1073\/pnas.1301331110","article-title":"Anti-VEGF- and anti-VEGF receptor-induced vascular alteration in mouse healthy tissues","volume":"110","author":"Yang","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107211201_b26-or-35-02-1041","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nrendo.2014.114","article-title":"VEGF-targeted cancer therapeutics-paradoxical effects in endocrine organs","volume":"10","author":"Cao","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"key20180107211201_b27-or-35-02-1041","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1006\/bbrc.1999.1586","article-title":"Sphingosine 1-phosphate induces angiogenesis: Its angiogenic action and signaling mechanism in human umbilical vein endothelial cells","volume":"264","author":"Lee","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180107211201_b28-or-35-02-1041","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/j.bbamcr.2008.04.006","article-title":"Interferon regulatory factor-1 (IRF-1) regulates VEGF-induced angiogenesis in HUVECs","volume":"1783","author":"Lee","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"key20180107211201_b29-or-35-02-1041","doi-asserted-by":"crossref","first-page":"10128","DOI":"10.1073\/pnas.93.19.10128","article-title":"Interaction between human tRNA synthetases involves repeated sequence elements","volume":"93","author":"Rho","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107211201_b30-or-35-02-1041","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.1073\/pnas.96.8.4488","article-title":"Genetic dissection of protein-protein interactions in multi-tRNA synthetase complex","volume":"96","author":"Rho","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107211201_b31-or-35-02-1041","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.cellsig.2011.08.013","article-title":"Programmed cell death 6 (PDCD6) inhibits angiogenesis through PI3K\/mTOR\/p70S6K pathway by interacting of VEGFR-2","volume":"24","author":"Rho","year":"2012","journal-title":"Cell Signal"},{"key":"key20180107211201_b32-or-35-02-1041","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/359845a0","article-title":"Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo","volume":"359","author":"Plate","year":"1992","journal-title":"Nature"},{"key":"key20180107211201_b33-or-35-02-1041","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/376553a0","article-title":"Signal transduction. A target for PI(3) kinase","volume":"376","author":"Downward","year":"1995","journal-title":"Nature"},{"key":"key20180107211201_b34-or-35-02-1041","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/43354","article-title":"Akt is more than just a Bad kinase","volume":"401","author":"Khwaja","year":"1999","journal-title":"Nature"},{"key":"key20180107211201_b35-or-35-02-1041","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.molmed.2005.06.007","article-title":"An expanding role for mTOR in cancer","volume":"11","author":"Guertin","year":"2005","journal-title":"Trends Mol Med"},{"key":"key20180107211201_b36-or-35-02-1041","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10456-005-9001-1","article-title":"Angiogenesis in normal and neoplastic ovaries","volume":"8","author":"Ramakrishnan","year":"2005","journal-title":"Angiogenesis"},{"key":"key20180107211201_b37-or-35-02-1041","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.bjc.6604767","article-title":"Antiangiogenic drugs in ovarian cancer","volume":"100","author":"Kumaran","year":"2009","journal-title":"Br J Cancer"},{"key":"key20180107211201_b38-or-35-02-1041","first-page":"587","article-title":"The prognostic significance of angiogenesis in epithelial ovarian carcinoma","volume":"5","author":"Alvarez","year":"1999","journal-title":"Clin Cancer Res"},{"key":"key20180107211201_b39-or-35-02-1041","first-page":"823","article-title":"Vascular endothelial growth factor levels in ovarian cyst fluid correlate with malignancy","volume":"5","author":"Hazelton","year":"1999","journal-title":"Clin Cancer Res"},{"key":"key20180107211201_b40-or-35-02-1041","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1016\/j.cellsig.2014.07.026","article-title":"WIF1 can effectively co-regulate pro-apoptotic activity through the combination with DKK1","volume":"26","author":"Ko","year":"2014","journal-title":"Cell Signal"},{"issue":"Suppl 16","key":"key20180107211201_b41-or-35-02-1041","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1053\/sonc.2002.37264","article-title":"Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: Therapeutic implications","volume":"29","author":"Ferrara","year":"2002","journal-title":"Semin Oncol"},{"key":"key20180107211201_b42-or-35-02-1041","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1111\/j.1349-7006.1996.tb02127.x","article-title":"Inhibition of growth and metastasis of ovarian carcinoma by administering a drug capable of interfering with vascular endothelial growth factor activity","volume":"87","author":"Mu","year":"1996","journal-title":"Jpn J Cancer Res"},{"key":"key20180107211201_b43-or-35-02-1041","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0304-3835(97)00350-9","article-title":"Vascular endothelial growth factor (VEGF) expression and survival in human epithelial ovarian carcinomas","volume":"121","author":"Hartenbach","year":"1997","journal-title":"Cancer Lett"},{"key":"key20180107211201_b44-or-35-02-1041","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/bjc.1997.537","article-title":"Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: Correlation with clinicopathology and patient survival, and analysis of serum VEGF levels","volume":"76","author":"Yamamoto","year":"1997","journal-title":"Br J Cancer"},{"key":"key20180107211201_b45-or-35-02-1041","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1210\/edrv.18.1.0287","article-title":"The biology of vascular endothelial growth factor","volume":"18","author":"Ferrara","year":"1997","journal-title":"Endocr Rev"},{"key":"key20180107211201_b46-or-35-02-1041","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3892\/or.2013.2928","article-title":"Suppression of VEGF expression through interruption of the HIF-1\u03b1 and Akt signaling cascade modulates the anti-angiogenic activity of DAPK in ovarian carcinoma cells","volume":"31","author":"Park","year":"2014","journal-title":"Oncol Rep"},{"key":"key20180107211201_b47-or-35-02-1041","first-page":"6253","article-title":"Complete inhibition of rhabdomyosarcoma xenograft growth and neovascularization requires blockade of both tumor and host vascular endothelial growth factor","volume":"60","author":"Gerber","year":"2000","journal-title":"Cancer Res"},{"key":"key20180107211201_b48-or-35-02-1041","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1023\/A:1006040928755","article-title":"New targets, drugs, and approaches for the treatment of cancer: An overview","volume":"17","author":"Kerbel","year":"1998","journal-title":"Cancer Metastasis Rev"},{"key":"key20180107211201_b49-or-35-02-1041","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1146\/annurev.cellbio.15.1.551","article-title":"Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1","volume":"15","author":"Semenza","year":"1999","journal-title":"Annu Rev Cell Dev Biol"},{"key":"key20180107211201_b50-or-35-02-1041","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/10409230091169186","article-title":"Hypoxia, clonal selection, and the role of HIF-1 in tumor progression","volume":"35","author":"Semenza","year":"2000","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"key20180107211201_b51-or-35-02-1041","first-page":"5830","article-title":"Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases","volume":"59","author":"Zhong","year":"1999","journal-title":"Cancer Res"},{"key":"key20180107211201_b52-or-35-02-1041","doi-asserted-by":"crossref","first-page":"8104","DOI":"10.1073\/pnas.94.15.8104","article-title":"Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth","volume":"94","author":"Maxwell","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107211201_b53-or-35-02-1041","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1096\/fj.04-2175com","article-title":"Apigenin inhibits VEGF and HIF-1 expression via PI3K\/AKT\/p70S6K1 and HDM2\/p53 pathways","volume":"19","author":"Fang","year":"2005","journal-title":"FASEB J"},{"key":"key20180107211201_b54-or-35-02-1041","doi-asserted-by":"crossref","first-page":"5853","DOI":"10.1038\/sj.onc.1207721","article-title":"AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth","volume":"23","author":"Altomare","year":"2004","journal-title":"Oncogene"},{"key":"key20180107211201_b55-or-35-02-1041","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nrm1911","article-title":"VEGF receptor signalling - in control of vascular function","volume":"7","author":"Olsson","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"key":"key20180107211201_b56-or-35-02-1041","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nrc2664","article-title":"Targeting PI3K signalling in cancer: Opportunities, challenges and limitations","volume":"9","author":"Engelman","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"key20180107211201_b57-or-35-02-1041","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1158\/2159-8290.CD-11-0170","article-title":"Genomic complexity and AKT dependence in serous ovarian cancer","volume":"2","author":"Hanrahan","year":"2012","journal-title":"Cancer Discov"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2015.4408\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T19:40:51Z","timestamp":1653507651000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2015.4408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,10]]},"references-count":57,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2015,11,10]]},"published-print":{"date-parts":[[2016,2]]}},"alternative-id":["10.3892\/or.2015.4408"],"URL":"https:\/\/doi.org\/10.3892\/or.2015.4408","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,10]]}}}